Literature DB >> 12237494

Brain activation pattern as assessed with multi-modal EEG analysis predict motor recovery among stroke patients with mild arm paresis who receive the Arm Ability Training.

T Platz1, I-H Kim, U Engel, A Kieselbach, K-H Mauritz.   

Abstract

PURPOSE: Receiving the Arm Ability Training for three weeks improves motor function among stroke patients with mild arm paresis. There is, however, a considerable variability in recovery among patients receiving the Arm Ability Training. The study investigated whether intersubject differences in movement-related electric brain activity explain the variability in motor recovery.
METHODS: In a sample of 9 patients receiving the Arm Ability Training both motor performance using a standardised arm function test (TEMPA) and movement-related electric brain activity, i.e. slow cortical potentials (DC) as well as event-related desynchronisation of alpha (alpha-ERD) and beta activity (beta-ERD), were assessed before the Arm Ability Training was started. Stepwise multiple regression was used to establish the best predictive model for motor improvement scores (TEMPA difference from pre to post test three weeks later).
RESULTS: Stepwise multiple regression indicated that electric brain activity during movement preparation explained the variance of motor improvement scores completely. Further, electric brain activity during movement as well as baseline motor performance accounted each for 50% of the variance of motor improvement scores.
CONCLUSIONS: Activation of sensorimotor areas during movement preparation and deactivation of other cortical areas during movement execution seem to be factors that predict a favourable outcome after training.

Entities:  

Mesh:

Year:  2002        PMID: 12237494

Source DB:  PubMed          Journal:  Restor Neurol Neurosci        ISSN: 0922-6028            Impact factor:   2.406


  7 in total

Review 1.  Imaging motor recovery after stroke.

Authors:  Nuray Yozbatiran; Steven C Cramer
Journal:  NeuroRx       Date:  2006-10

2.  ERD-based online brain-machine interfaces (BMI) in the context of neurorehabilitation: optimizing BMI learning and performance.

Authors:  Surjo R Soekadar; Matthias Witkowski; Jürgen Mellinger; Ander Ramos; Niels Birbaumer; Leonardo G Cohen
Journal:  IEEE Trans Neural Syst Rehabil Eng       Date:  2011-10       Impact factor: 3.802

3.  Botulinum Toxin Type A Improves Function According to Goal Attainment in Adults with Poststroke Lower Limb Spasticity in Real Life Practice.

Authors:  Lourdes López de Munain; Josep Valls-Solé; Irene Garcia Pascual; Pascal Maisonobe
Journal:  Eur Neurol       Date:  2019-11-14       Impact factor: 1.710

4.  The Prognostic Utility of Electroencephalography in Stroke Recovery: A Systematic Review and Meta-Analysis.

Authors:  Amanda A Vatinno; Annie Simpson; Viswanathan Ramakrishnan; Heather S Bonilha; Leonardo Bonilha; Na Jin Seo
Journal:  Neurorehabil Neural Repair       Date:  2022-03-20       Impact factor: 3.919

5.  Corticospinal excitability as a predictor of functional gains at the affected upper limb following robotic training in chronic stroke survivors.

Authors:  Marie-Hélène Milot; Steven J Spencer; Vicky Chan; James P Allington; Julius Klein; Cathy Chou; Kristin Pearson-Fuhrhop; James E Bobrow; David J Reinkensmeyer; Steven C Cramer
Journal:  Neurorehabil Neural Repair       Date:  2014-03-18       Impact factor: 3.919

Review 6.  Rehabilitation of gait after stroke: a review towards a top-down approach.

Authors:  Juan-Manuel Belda-Lois; Silvia Mena-del Horno; Ignacio Bermejo-Bosch; Juan C Moreno; José L Pons; Dario Farina; Marco Iosa; Marco Molinari; Federica Tamburella; Ander Ramos; Andrea Caria; Teodoro Solis-Escalante; Clemens Brunner; Massimiliano Rea
Journal:  J Neuroeng Rehabil       Date:  2011-12-13       Impact factor: 4.262

7.  Brain oscillatory activity as a biomarker of motor recovery in chronic stroke.

Authors:  Andreas M Ray; Thiago D C Figueiredo; Eduardo López-Larraz; Niels Birbaumer; Ander Ramos-Murguialday
Journal:  Hum Brain Mapp       Date:  2019-11-28       Impact factor: 5.038

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.